Academic Journal
Q1The Lancet Psychiatry
About The Lancet Psychiatry
The Lancet Psychiatry is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 8.07 and an H-index of 176.
Its listed coverage is 2014-2026 and its research categories include Biological Psychiatry (Q1); Psychiatry and Mental Health (Q1). The 2025 dataset reports 195 documents and 5888 citations across the latest three-year reporting window.
The Lancet Psychiatry is one of the most renowned medical journals in the world, dedicated to advancing the field of psychiatry and mental health. Established as part of The Lancet family of journals, it focuses on publishing high-quality research, reviews, and opinion articles on the various aspects of mental health, ranging from clinical psychiatry to global mental health challenges.
Overview of The Lancet Psychiatry
The Lancet Psychiatry is a peer-reviewed journal that covers a wide array of topics within the field of psychiatry. It includes original research, clinical trials, expert reviews, and policy discussions. The journal has become a go-to resource for healthcare professionals, researchers, and policymakers who seek the latest developments in mental health science. It provides an authoritative platform for the discussion of mental health disorders, from common conditions such as depression and anxiety to more complex issues such as schizophrenia, bipolar disorder, and neurodegenerative diseases.
Scope and Content of The Lancet Psychiatry
The journal covers a diverse range of subjects related to psychiatry, including but not limited to:
-
Clinical Psychiatry: Research into the diagnosis, treatment, and management of mental health disorders. The Lancet Psychiatry regularly publishes clinical trials on pharmacological interventions, psychotherapy, and innovative treatments.
-
Psychiatric Epidemiology: Articles that explore the prevalence, risk factors, and social determinants of mental health disorders across different populations. This includes research on mental health disparities, as well as global trends in psychiatric conditions.
-
Neuroscience and Neurobiology: The Lancet Psychiatry also delves into the latest findings in brain science, offering insights into the neurological basis of mental health conditions. The journal publishes studies on biomarkers, neuroimaging, and neurodevelopmental factors.
-
Global Mental Health: With increasing awareness of mental health issues worldwide, The Lancet Psychiatry is dedicated to publishing research on global mental health challenges, with a particular focus on low- and middle-income countries. The journal highlights the mental health impacts of conflict, migration, and poverty, and it discusses strategies to improve mental health care access in underserved regions.
-
Psychiatric Policy and Advocacy: The journal plays a key role in shaping mental health policy by providing evidence-based recommendations and advocating for better mental health care infrastructure globally. It often publishes reports and commentaries on policy initiatives, mental health legislation, and the economic impact of mental health disorders.
Why The Lancet Psychiatry is Important
The Lancet Psychiatry stands out as a critical resource for advancing mental health knowledge. The journal’s rigorous peer-review process ensures that it publishes only the highest quality research, making it a trusted source for clinicians, researchers, and policymakers. Its multidisciplinary approach to psychiatry reflects the complex nature of mental health, considering not only biological factors but also social, cultural, and environmental influences.
Moreover, The Lancet Psychiatry plays an essential role in increasing public awareness about mental health. Through its widely read articles, it helps reduce the stigma surrounding mental health disorders, promotes better understanding, and encourages the implementation of effective, evidence-based practices in the treatment and management of mental illnesses.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Lancet Psychiatry The Lancet Psychiatry is one of the most prestigious peer-reviewed medical journals, focused on publishing high-quality research in the field of psychiatry and mental health. As part of the renowned Lancet family of journals, it addresses both clinical and scientific advancements in psychiatry. Its global reach and impact make it a key resource for researchers, clinicians, and policymakers in the mental health space.
Research Areas Covered by The Lancet Psychiatry The Lancet Psychiatry explores a wide array of topics within psychiatry and mental health. Its scope encompasses both basic and clinical research, with a strong focus on the scientific underpinnings of mental health disorders and their treatment. Some of the primary areas of research include:
-
Psychiatric Disorders and Treatment Approaches The journal provides in-depth articles on a variety of psychiatric disorders such as depression, schizophrenia, bipolar disorder, anxiety, and autism spectrum disorders. It emphasizes novel treatment approaches, including pharmacological interventions, psychotherapy, and emerging therapies such as gene therapy and personalized medicine.
-
Neuroscience and Mental Health Understanding the biological basis of mental illness is a key focus. Research articles often explore the role of neurobiology, genetics, and brain structure in the development of psychiatric conditions. The Lancet Psychiatry also covers studies on brain imaging techniques, neuroplasticity, and how the brain's structure and function are affected by mental health disorders.
-
Public Health and Policy in Mental Health The Lancet Psychiatry plays a pivotal role in shaping mental health policy globally. It regularly publishes research that examines the effectiveness of mental health interventions, the impact of mental health on public health systems, and strategies for improving mental health care worldwide. Additionally, it explores issues related to stigma, access to care, and the social determinants of mental health.
-
Mental Health Across the Lifespan The journal highlights mental health issues in different age groups, from childhood to older adulthood. It includes studies on early interventions for childhood psychiatric disorders, the mental health challenges faced by adolescents, and mental health care for the elderly. As populations age globally, geriatric psychiatry is becoming an increasingly important topic.
-
Psychiatric Epidemiology The Lancet Psychiatry publishes epidemiological studies that track the prevalence, incidence, and risk factors associated with mental health conditions across different populations. These studies are crucial for understanding the global burden of psychiatric diseases and the demographic factors that influence mental health outcomes.
Impact and Influence of The Lancet Psychiatry As a leading journal, The Lancet Psychiatry has a significant influence on the global mental health landscape. It offers cutting-edge research that informs both clinical practice and public health policy. Its findings often lead to major advancements in the treatment and understanding of mental health conditions, paving the way for improved patient outcomes and innovative therapeutic strategies.
Moreover, the journal’s commitment to publishing high-quality, evidence-based research ensures that it remains a valuable resource for researchers, mental health professionals, and educators alike. With its strong editorial standards and global perspective, The Lancet Psychiatry continues to set the benchmark for psychiatry journals worldwide.
Recent Research Articles
Latest publications matched automatically by ISSN.
New clozapine regulations, old inequalities?
Ebenezer Oloyede, Eromona Whiskey, David Taylor
2026-09 · DOI: 10.1016/s2215-0366(26)00232-4Questions AI cannot answer
The Lancet Psychiatry
2026-09 · DOI: 10.1016/s2215-0366(26)00242-7Marketing of supplements to people with ADHD reinforces stigma
Ava C Wilson
2026-09 · DOI: 10.1016/s2215-0366(26)00114-8Mark Rapaport—aiming to leave a better world than he found
Tony Kirby
2026-09 · DOI: 10.1016/s2215-0366(26)00233-6Incidence of systemic physical multimorbidity among people with schizophrenia-spectrum or bipolar-spectrum disorders compared with age-matched and sex-matched individuals in Queensland, Australia: a statewide, hospital cohort study
Sean Halstead, Nicola Warren, Steve Kisely, Urska Arnautovska et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00196-3Priority is not equity: lessons from COVID-19 for people with severe mental illness
Delphine Capdevielle, Stéphane Raffard
2026-09 · DOI: 10.1016/s2215-0366(26)00234-8Beyond task sharing: the next step for global mental health
Laura Shields-Zeeman, Felix Bolinski
2026-09 · DOI: 10.1016/s2215-0366(26)00236-1Optimising and personalising task-shared psychosocial interventions for common mental disorders: a Bayesian component network meta-analysis of individual participant data
Davide Papola, Federico Tedeschi, Orestis Efthimiou, Mathias Harrer et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00193-8Research priorities for metabolic interventions in severe mental illness: results of a James Lind Alliance Priority Setting Partnership
Dina Farran, Maria Kapi, Kate Moffat, Melanie Stratford et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00129-xInequalities in mortality following SARS-CoV-2 infection for people with severe mental illness during and following vaccination roll-out in England: a retrospective, whole-country linked cohort study
Natasha Chilman, Laia Bécares, Alexandru Dregan, Amy Ronaldson et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00195-1Early prevention of multimorbidity for those with severe mental illness
Tomáš Formánek, Oleguer Plana-Ripoll, Linda Ejlskov
2026-09 · DOI: 10.1016/s2215-0366(26)00237-3AI scribe functions in psychiatric practice: clinical oversight, consent, and regulation
Alexander S Roth, Nolan B Ayers
2026-09 · DOI: 10.1016/s2215-0366(26)00201-4US FDA premarket approval of tDCS depression treatment is not yet scientifically justified
Jana Klaus, Fenne M Smits, André Aleman, Chris Baeken et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00092-1Correction to Lancet Psychiatry 2026; 13: 376–86
2026-09 · DOI: 10.1016/s2215-0366(26)00206-3Structural brain changes and clinical outcomes of patients with NMDA receptor encephalitis in Germany: a cross-sectional study
Stephan Krohn, Guido Cammà, Wei Zhao, Amy Romanello et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00191-4Multidisciplinary research priorities for artificial intelligence in mental health: a call to action
Jake Linardon, Joseph Firth, Andre F Carvalho, Claudi L Bockting et al.
2026-09 · DOI: 10.1016/s2215-0366(26)00127-6Enduring NMDA receptor encephalitis
Eunice Phillips, Sophie N M Binks, Adam Al-Diwani
2026-09 · DOI: 10.1016/s2215-0366(26)00226-9Precision language in ADHD research
Stephen V Faraone, Michael J Miller
2026-09 · DOI: 10.1016/s2215-0366(26)00117-3Correction to Lancet Psychiatry 2023; 10: 209–19
2026-09 · DOI: 10.1016/s2215-0366(26)00224-5Correction to Lancet Psychiatry 2026; 13: 783–91
2026-08 · DOI: 10.1016/s2215-0366(26)00264-6Reviews
Community Reviews
Version History
April 14, 2025 at 5:14 pm
April 14, 2025